Regeno Blend (BPC-157, TB-500, Cartalax) 30mg

$140.00

Triple peptide blend combining BPC-157, TB-500, and Cartalax at 10mg each for in vitro connective tissue studies.

Category: Vials

Description
Reviews (0)

Peptide Blend Description

This 30mg research blend delivers three complementary peptides in a single vial: BPC-157, TB-500, and Cartalax. Each component contributes distinct mechanisms for laboratory research. BPC-157 (10mg) targets gastric-derived pathways. TB-500 (10mg) provides the 43-amino acid thymosin beta-4 sequence. Cartalax (10mg) offers the bioregulatory AED tripeptide.

Manufactured in USA facilities under pharmaceutical-grade standards with third-party testing verification. Supplied as sterile lyophilized powder at ≥99% purity. Designed for researchers studying connective tissue mechanisms, cellular repair pathways, and fibroblast activity in controlled laboratory settings. For in vitro research applications only.

Product Specifications

Specification	BPC-157	TB-500 (Thymosin Beta-4)	Cartalax (AED)
Sequence	Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val	Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser	Ala-Glu-Asp
Molecular Formula	C₆₂H₉₈N₁₆O₂₂	C₂₁₂H₃₅₀N₅₆O₇₈S	C₁₂H₁₉N₃O₈
Molecular Weight	1419.5 g/mol	4963.4 g/mol	333.29 g/mol
CAS Number	137525-51-0	77591-33-4	205640-90-0
PubChem CID	9941957	16132341	87815447
Synonyms	Bepecin, Bpc 15, Body protection compound 15, Pentadecapeptide	Thymosin Beta 4, Thymosin β4, TB500, Timbetasin	T-31, AED, Alanyl-glutamyl-aspartic acid

Product Usage:

This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug.